John T. Potts

Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 16, 2023

The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: August 02, 2022

Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice.

Journal: Endocrinology

Published: March 14, 2022

Management of Primary Hyperparathyroidism.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 11, 2022

Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 11, 2022

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 10, 2022

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long-Acting PTH Analog (LA-PTH).

Journal: JBMR plus

Published: March 20, 2020

An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: March 15, 2019

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 10, 2016

Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone.

Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone.

The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism.

The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism.

Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice.

Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice.

Management of Primary Hyperparathyroidism.

Management of Primary Hyperparathyroidism.

Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.

Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long-Acting PTH Analog (LA-PTH).

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long-Acting PTH Analog (LA-PTH).

An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.

An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.

Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment.

Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment.

Management of Hypoparathyroidism: Summary Statement and Guidelines.

Management of Hypoparathyroidism: Summary Statement and Guidelines.

Management of Hypoparathyroidism: Present and Future.

Management of Hypoparathyroidism: Present and Future.

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.